Federated Hermes, Inc. Gilead Sciences, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 7,129,746 shares of GILD stock, worth $670 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

7,129,746

Previous 6,321,167 12.79%

Holding current value

$670 Million

Previous $434 Million 37.8%

% of portfolio

1.37%

Previous 1.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $53.8 Million - $67.9 Million	808,579 Added 12.79%	7,129,746 $598 Million
Q2 2024 Aug 08, 2024	BUY	$63.15 - $72.88 $65.5 Million - $75.6 Million	1,036,932 Added 19.62%	6,321,167 $434 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $107 Million - $131 Million	1,496,880 Added 39.52%	5,284,235 $387 Million
Q4 2023 Jan 31, 2024	BUY	$73.27 - $83.09 $12.9 Million - $14.6 Million	175,925 Added 4.87%	3,787,355 $307 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $1.54 Million - $1.68 Million	20,799 Added 0.58%	3,611,430 $271 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $156 Million - $178 Million	-2,050,261 Reduced 36.35%	3,590,631 $277 Million
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $133 Million - $151 Million	-1,716,591 Reduced 23.33%	5,640,892 $468 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $48.6 Million - $69.7 Million	-779,455 Reduced 9.58%	7,357,483 $632 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $9.64 Million - $11 Million	161,902 Added 2.03%	8,136,938 $502 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $58.2 Million - $65.6 Million	1,008,339 Added 14.47%	7,975,036 $493 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $34.1 Million - $42.7 Million	588,734 Added 9.23%	6,966,697 $414 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $7.76 Million - $8.81 Million	119,615 Added 1.91%	6,377,963 $463 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $8.63 Million - $9.32 Million	127,562 Added 2.08%	6,258,348 $437 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.57 Million - $1.72 Million	24,756 Added 0.41%	6,130,786 $422 Million
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $5.24 Million - $5.98 Million	87,287 Added 1.45%	6,106,030 $395 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $49.6 Million - $56.6 Million	876,362 Added 17.04%	6,018,743 $351 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $182 Million - $229 Million	2,936,687 Added 133.14%	5,142,381 $325 Million
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $357 Million - $414 Million	-4,930,612 Reduced 69.09%	2,205,694 $170 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $95.6 Million - $122 Million	1,526,835 Added 27.22%	7,136,306 $534 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.95 Million - $2.15 Million	31,684 Added 0.57%	5,609,471 $365 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $332 Million - $367 Million	5,317,848 Added 2045.81%	5,577,787 $354 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $449,361 - $503,906	-7,263 Reduced 2.72%	259,939 $17.6 Million
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $1.31 Million - $1.47 Million	-20,953 Reduced 7.27%	267,202 $17.4 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $3.39 Million - $4.43 Million	56,053 Added 24.15%	288,155 $18 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $14.3 Million - $15.9 Million	201,089 Added 648.4%	232,102 $17.9 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $187,632 - $218,866	-2,892 Reduced 8.53%	31,013 $2.2 Million
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $19.5 Million - $23.7 Million	-267,391 Reduced 88.75%	33,905 $2.56 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $6.67 Million - $7.82 Million	93,682 Added 45.12%	301,296 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $15 Million - $17.7 Million	207,614	207,614 $16.8 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Gilead Sciences, Inc. Transaction History